Komori
General Meetings of Shareholders4896K Pharma,Inc.Pharmaceuticals

Notice of the Convocation of the 9th Annual General Meeting of Shareholders and Meeting Materials

The 9th Annual General Meeting of Shareholders will be held on 26 March 2026, with proposals for the reduction of capital reserves and offsetting the deficit through surplus, and a change of auditor, to be submitted for approval.

Worth reading
52Recurring
Scored from 3 of 4 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
993227458
¥
Wording
Conditional
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (9th)
2026
Mar 26
Date and time(Thursday), 10:00 a.m.22 days from this disclosure to the meeting
Matters for resolution2 items
  1. 資本準備金の額の減少並びに剰余金の処分の件

  2. 会計監査人の選任の件

Shareholder Proposal

No

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (9th)
Date and time26 March 2026 (Thursday), 10:00 a.m.
Matters for resolution第1号議案 資本準備金の額の減少並びに剰余金の処分の件, 第2号議案 会計監査人の選任の件
Shareholder ProposalNo
Items this document does not state (2)
Director nomineePercentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

利益剰余金の欠損を填補し、財務体質を健全化するとともに、今後の資本政策の柔軟性・機動性を確保するため。会計監査人については、独立性、専門性、監査の実施状況、品質管理体制等を総合的に勘案し、新たな視点での監査が期待できるため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of the Convocation of the 9th Annual General Meeting of Shareholders and Meeting Materials | K Pharma,Inc. (4896) timely disclosure | Komori